Advertisement
The presentation by Scott Huennekens, president and chief executiveofficer, will begin at 8 a.m., Eastern Daylight Time (5 a.m., Pacific DaylightTime).
Advertisement
The presentation will be available through the conference website athttp://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=VOLC&item_id=1887632,or via the company's website at http://www.volcanocorp.com.
Volcano Corporation (Nasdaq: VOLC) offers a broad suite of devicesdesigned to facilitate endovascular procedures, enhance the diagnosis ofvascular and structural heart disease and guide optimal therapies. Thecompany's intravascular ultrasound (IVUS) product line includes ultrasoundconsoles that can be integrated directly into virtually any modern cath lab.Volcano IVUS offers unique features, including both single-use phased arrayand rotational IVUS imaging catheters, and advanced functionality options,such as VH(TM) tissue characterization and ChromaFlo(R). Volcano also providesfunctional measurement (FM) consoles and single-use pressure and flow guidewires and is developing a line of ultra-high resolution Optical CoherenceTomography (OCT) systems and catheters. Currently, more than 3,500 VolcanoIVUS and FM systems are installed worldwide, with approximately half of itsrevenues coming from outside the United States. For more information, visitthe company's website at http://www.volcanocorp.com
SOURCE Volcano Corporation
